Antiapoptotic effect of EGF on mouse hepatocytes associated with downregulation of proapoptotic Bid protein

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 285, Issue 2 48-2, 2003, Pages

  Éthier, Chantal ^a   Raymond, Valérie Ann ^a   Musallam, Lina ^a   Houle, Robert ^a   Bilodeau, Marc ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Bcl 2 family proteins; Caspases; Cell death; Fas signal

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FAS ANTIBODY; FAS ANTIGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN P15;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; CELL PROTECTION; CONTROLLED STUDY; DOWN REGULATION; LIVER CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; SIGNAL TRANSDUCTION;

EID: 0038442090     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.00040.2003     Document Type: Article

References (58)

1. Ashkenazi A and Dixit VM. Death receptors: signaling and modulation. Science 281: 1305-1308, 1998.
2. Bajt ML, Lawson JA, Vonderfecht SL, Gujral JS, and Jaeschke H. Protection against Fas receptor-mediated apoptosis in hepatocytes and nonparenchymal cells by a caspase-8 inhibitor in vivo: evidence for a postmitochondrial processing of caspase-8. Toxicol Sci 58: 109-117, 2000.
3. Barry M, Heibein JA, Pinkoski MJ, Lee SF, Moyer RW, Green DR, and Bleackley RC. Granzyme B short circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid. Mol Cell Biol 20: 3781-3794, 2000.
4. Boldin MP, Goncharov TM, Goltsev YV, and Wallach D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 85: 803-815, 1996.
5. Bossy-Wetzel E and Green DG. Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J Biol Chem 274: 17484-17490, 1999.
6. Boudreau N, Symspon CJ, Werb Z, and Bissell MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267: 891-893, 1995.
7. Boyd JM, Gallo GJ, Elangovan B, Houghton AB, Malstrom S, Avery BJ, Ebb EG, Subramanian T, Chittenden T, Lutz RJ, and Chinnadurai G. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11: 1921-1928, 1995.
8. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
9. Conway EM, Pollefeyt S, Steiner-Mosonyi M, Luo W, Devriese A, Lupu F, Bono F, Leducq N, Dol F, Schaeffer P, Collen D, and Herbert JM. Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways. Gastroenterology 123: 619-631, 2002.
10. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y, and Greenberg ME. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-241, 1997.
11. De Smet K, Loyer P, Gilot D, Vercruysse A, Rogiers V, and Guguen-Guillouzo C. Effects of epidermal growth factor on CYP inducibility by xenobiotics, DNA replication, and caspase activations in collagen I gel sandwich cultures of rat hepatocytes. Biochem Pharmacol 61: 1293-1303, 2001.
12. Del Peso L, Gonzalez-Garcia M, Page C, Herrera R, and Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 278: 687-689, 1997.
13. Desagher S, Osen-Sand A, Montessuit S, Magnenat E, Vilbois F, Hochmann A, Journot L, Antonsson B, and Martinou JC. Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol Cell 8: 601-611, 2001.
14. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, Maundrell K, Antonsson B, and Martinou JC. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 144: 891-901, 1999.
15. Dimmeler S, Breitschopf K, Haendeler J, and Zeiher AM. Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway. J Exp Med 189: 1815-1822, 1999.
16. Eskes R, Desagher S, Antonsson B, and Martinou JC. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol 20: 929-935, 2000.
17. Fabregat I, Sanchez A, Alvarez AM, Nakamura T, and Benito M. Epidermal growth factor, but not hepatocyte growth factor, suppresses the apoptosis induced by transforming growth factor-β in fetal hepatocytes in primary culture. FEBS Lett 384: 14-18, 1996.
18. Fladmark KE, Gjertsen BT, Doskeland SO, and Vintermyr OK. Fas/APO-1 (CD95)-induced apoptosis of primary hepatocytes is inhibited by cAMP. Biochem Biophys Res Commun 232: 20-25, 1997.
19. Franke TF, Yang SI, Chan TO, Datta D, Kazlauskas A, Morrison DK, Kaplan DR, and Tsichlis PN. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell 81: 727-736, 1995.
20. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, Krammer PH, and Runkell L. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182: 1223-1230, 1995.
21. L prevents this release but not tumor necrosis factor-R1/Fas death. J Biol Chem 274: 1156-1163, 1999.
22. Han Z, Bhalla K, Pantazis P, Hendrickson EA, and Wyche JH. Cif (cytochrome c efflux-inducing factor) activity is regulated by Bcl-2 and caspases and correlates with the activation of Bid. Mol Cell Biol 19: 1381-1389, 1999.
23. Higaki K, Yano H, and Kojiro M. Fas antigen expression and its relationship with apoptosis in human hepatocellular carcinoma and noncancerous tissues. Am J Pathol 149: 429-437, 1996.
24. Higuchi J, Miyoshi H, Bronk SF, Zhang H, Dean N, and Gores GJ. Bid antisense attenuates bile acid-induced apoptosis and cholestatic liver injury. J Pharmacol Exp Ther 299: 866-873, 2001.
25. Hiramatsu N, Yayashi N, Katayama K, Mochizuki K, Kawanishi Y, Kasahara A, Fusamoto H, and Kamada T. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19: 1354-1359, 1994.
26. Kaplowitz N. Cell death at the millennium. Implications for liver diseases. Clin Liver Dis 4: 1-23, 2000.
27. Kim PK, Wang Y, Gambotto A, Kim YM, Weller R, Zuckerbraun BS, Hua Y, Watkins SC, and Billiar TR. Hepatocyte Fas-associating death domain protein/mediator of receptor-induced toxicity (FADD/MORT1) levels increase in response to pro-apoptotic stimuli. J Biol Chem 277: 38855-38862, 2002.
28. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, and Peter ME. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J 14: 5579-5588, 1995.
29. Korsmeyer SJ, Wei MC, Saito M, Weiler S, Oh KJ, and Schlesinger PH. Pro-apoptotic cascade activates BID, which oligomerizes BAK or BAX into pores that result in the release of cytochrome c. Cell Death Differ 7: 1166-1173, 2000.
30. Kosai K, Matsumoto K, Nagata S, Tsujimoto Y, and Nakamura T. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun 244: 683-690, 1998.
31. Li H, Zhu H, Xu CJ, and Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501, 1998.
32. Liedtke C, Plumpe J, Kubicka S, Bradham CA, Manns MP, Brenner DA, and Trautwein C. Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cells. Hepatology 36: 315-325, 2002.
33. Luo X, Budinard JO, Zou H, Slaughter C, and Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94: 481-490, 1998.
34. Musallam L, Ethier C, Haddad PS, and Bilodeau M. Role of EGFR tyrosine kinase activity in antiapoptotic effect of EGF on mouse hepatocytes. Am J Physiol Gastrointest Liver Physiol 280: G1360-G1369, 2001.
35. Musallam L, Ethier C, Haddad PS, Denizeau F, and Bilodeau M. Resistance to Fas-induced apoptosis in hepatocytes: role of GSH depletion by cell isolation and culture. Am J Physiol Gastrointest Liver Physiol 283: G709-G718, 2002.
36. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, and Dixit VM. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 85: 817-827, 1996.
37. Ni R, Tomita Y, Matsuda K, Ichihara A, Ishimura K, Ogasawara J, and Nagata S. Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp Cell Res 215: 332-337, 1994.
38. Ogasawara J, Watanabe-Fukunaga R, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, and Nagata S. Lethal effect of the anti-Fas antibody in mice. Nature 364: 806-809, 1993.
39. Oltvai ZN, Milliman CL, and Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619, 1993.
40. Park SY and Seol DW. Regulation of Akt by EGF-R inhibitors, a possible mechanism of EGF-R inhibitor-enhanced TRAIL-induced apoptosis. Biochem Biophys Res Commun 295: 515-518, 2002.
41. Rivero M, Crespo J, Mayorga M, Fabrega E, Casafont F, and Pons-Romero F. Involvement of the Fas system in liver allograft rejection. Am J Gastroenterol 97: 1501-1506, 2002.
42. Roberts RA, James NH, and Cosulich SC. The role of protein kinase B and mitogen-activated protein kinase in epidermal growth factor and tumor necrosis factor alpha-mediated rat hepatocyte survival and apoptosis. Hepatology 31: 420-427, 2000.
43. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, and Peter ME. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 17: 1675-1687, 1998.
44. Scaffidi C, Schmitz I, Zha J, Korsmeyer SJ, Krammer PH, and Peter ME. Differential modulation of apoptosis sensitivity in CD95 type I and type II cells. J Biol Chem 274: 22532-22538, 1999.
45. Sutton VR, Davis JE, Cancilla M, Johnstone RW, Ruefli AA, Sedelies K, Browne KA, and Trapani JA. Initiation of apoptosis by granzyme B requires direct cleavage of Bid, but not direct granzyme B-mediated caspase activation. J Exp Med 192: 1403-1414, 2000.
46. Suzuki A, Hayashida M, Kawano H, Sugimoto K, Nakano T, and Shiraki K. Hepatocyte growth factor promotes cell survival from Fas-mediated cell death in hepatocellular carcinoma cells via Akt activation and Fas-death-inducing signaling complex suppression. Hepatology 32: 796-802, 2000.
47. Takikawa Y, Miyoshi H, Rust C, Roberts P, Siegel R, Mandal PK, Millikan RE, and Gores GJ. The bile acid-activated phosphatidylinositol 3-kinase pathway inhibits Fas apoptosis upstream of Bid in rodent hepatocytes. Gastroenterology 120: 1810-1817, 2001.
48. Talapatra S and Thompson CB. Growth factor signalling in cell survival: implications for cancer treatment. J Pharmacol Exp Ther 298: 873-878, 2001.
49. Tan KO, Tan KM, and Yu VC. A novel BH3-like domain in BID is required for intramolecular interaction and autoinhibition of pro-apoptotic activity. J Biol Chem 274: 23687-23690, 1999.
50. Wang K, Yin XM, Chao DT, Milliman CL, and Korsmeyer SJ. Bid: a novel BH3 domain-only death agonist. Genves Dev 10: 2859-2869, 1996.
51. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, and Nagata S. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 148: 1274-1279, 1992.
52. Webster CR and Anwer MS. Phosphoinositide 3-kinase, but not mitogen-activated protein kinase, pathway is involved in hepatocyte growth factor-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes. Hepatology 33: 608-615, 2001.
53. Wei MC, Zong WX, Cheng EH, Lindsten T, Panoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson CB, and Korsmeyer SJ. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292: 727-730, 2001.
54. Yamaguchi H and Wang HG. The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change. Oncogene 20: 7779-7786, 2001.
55. Yin XM. Signal transduction mediated by Bid, a pro-death Bcl-2 family protein, connects the death receptor and mitochondria apoptosis pathways. Cell Res 10: 161-167, 2000.
56. Yin XM, Wang K, Gross A, Zhao Y, Zinkel S, Klocke B, Roth KA, and Korsmeyer SJ. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis, Nature 400: 886-891, 1999.
57. L. Cell 87: 619-628, 1996.
58. Zhao Y, Li S, Childs EE, Kuharsky DK, and Yin XM. Activation of pro-death Bcl-2 family proteins and mitochondria apoptosis pathway in tumor necrosis factor-α-induced liver injury, J Biol Chem 276: 27432-27440, 2001.